NHS rolls out national genetic test to reduce risk of donor kidney failure
Posted:
Hundreds of potential kidney donors of Black African and Black Caribbean heritage can now get a simple blood test to help reduce the risk of kidney failure.
Professor Bola Owolabi, Director of the National Healthcare Inequalities Improvement Programme, NHS England, said: “This is a great step forward in narrowing the gap in kidney health and tackling healthcare inequalities faced by Black African and Black Caribbean donors. This new genetic test will help make kidney donation safer for those who are generously willing to help others, while also enabling the NHS to help donors live longer and healthier lives.”
Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities.
Read more here.
Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS.
Read more here.